Leung Ying Ying, Fong Warren, Lui Nai Lee, Thumboo Julian
Department of Rheumatology and Immunology, Singapore General Hospital, The Academia, level 4, 20 College Road, Singapore, 169856, Singapore.
Duke-NUS Medical School, Singapore, Singapore.
Clin Rheumatol. 2017 Jan;36(1):125-131. doi: 10.1007/s10067-016-3460-1. Epub 2016 Oct 30.
Geographic differences in manifestation of psoriatic arthritis (PsA) could be related to differences in genetic or environmental factors. We aimed to compare the disease activity and functional status using validated outcome measures among patients with PsA of different ethnicities living in the same environment. We performed a cross-sectional study on consecutive patients with PsA classified by the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria from a single center. Sociodemographic data, clinical variables, and patient-reported outcomes were collected using a standardized protocol. Disease activities were assessed by validated composite scores: clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA), Composite Psoriatic Disease Activity Index (CPDAI), and minimal disease activity (MDA). Physical function was assessed with Health Assessment Questionnaire (HAQ) and the Medical Outcome Study Short-Form 36 (SF36) physical function subscales. Linear regression analyses were performed to identify variables associated with disease activities and physical function. Ninety-eight patients (51.5%, men) with mean (±SD) age and duration of PsA of 51.5 ± 13.8 and 5.5 ± 8.4 years were recruited. Indian was overrepresented compared with the national distribution of ethnicities. Compared to Chinese, Indian patients were more likely to be using biological therapies, have higher tender joint count, and worse enthesitis. Higher proportion of Indians had higher disease activity categories measured by cDAPSA, CPDAI, and MDA and had poorer physical function. In the multivariable analysis, ethnicity was significantly associated with HAQ and SF36-PF. Compared to Chinese, Indians with PsA living in the same environment had worse disease activity and physical function measured by validated outcomes.
银屑病关节炎(PsA)临床表现的地域差异可能与遗传或环境因素的差异有关。我们旨在使用经过验证的结局指标,比较生活在同一环境中的不同种族PsA患者的疾病活动度和功能状态。我们对来自单一中心、根据银屑病关节炎分类标准(CASPAR)分类的连续性PsA患者进行了一项横断面研究。使用标准化方案收集社会人口统计学数据、临床变量和患者报告的结局。通过经过验证的综合评分评估疾病活动度:银屑病关节炎临床疾病活动指数(cDAPSA)、银屑病综合疾病活动指数(CPDAI)和最小疾病活动度(MDA)。使用健康评估问卷(HAQ)和医学结局研究简明健康调查问卷36项(SF36)身体功能分量表评估身体功能。进行线性回归分析以确定与疾病活动度和身体功能相关的变量。招募了98例患者(51.5%为男性),PsA的平均(±标准差)年龄和病程分别为51.5±13.8岁和5.5±8.4年。与全国种族分布相比,印度人占比过高。与中国人相比,印度患者更可能正在使用生物疗法,压痛关节计数更高,肌腱端炎更严重。更高比例的印度人在cDAPSA、CPDAI和MDA测量中疾病活动度类别更高,身体功能更差。在多变量分析中,种族与HAQ和SF36身体功能(SF36-PF)显著相关。与中国人相比,生活在同一环境中的印度PsA患者经经过验证的结局指标测量,疾病活动度和身体功能更差。